Iran Vows to Never Bow as Trump Rejects Counteroffer Prolonging Middle East Conflict and Straining Energy Markets DocuSign DOCU Q1 2026 Earnings Beat Revenue NA EPS 101 Why Nova NVMI Just Dropped 844 What to Watch 20260515 Russias Oil Exports Hold Steady Despite US Sanctions Goldman Sachs Reports SpaceX Launches Starship Test Flight on Second Attempt Marking Key Milestone for Private Space Industry TechnologyDriven Healthcare Transformation Ushering a New Era of Medicine HighYield Savings Rates Remain Attractive Top Accounts Offer Up to 41 APY May 2026 MegaIPOs from SpaceX and OpenAI Spark Market Top Concerns as Record Floats Approach Prediction Market Investments Persist Despite Regulatory Uncertainty Goldman Sachs Highlights Modest Beauty Sales Growth Amid Volume Contraction Docebo Q1 2026 Earnings Narrow EPS Miss Positive Market Reception Despite Limited Disclosures TME Q1 2026 Earnings EPS Beat Fails to Lift Shares EHTH Q1 2026 Earnings EPS Misses Estimates by 3466 Shares Fall 37 PASG Q1 2026 Earnings NarrowerThanExpected Loss Drives Positive Market Reaction Perrigo PRGO Q1 2026 Earnings EPS Beats Estimates by 345 Stock Declines Slightly SPB Q1 2026 Earnings Strong EPS Beat Drives Share Gains Despite Missing Revenue Details 3D Systems DDD Rallies 535 as Support Holds at 299 CenterPoint Energy CNP Edges Higher Resilience in a Volatile Utility Landscape Prudential Financial Preferred PRH Edges Lower Amid YieldDriven Correction Gladstone Commercial Preferred Stock GOODO Edges Higher Amid Steady Yield Demand Silexion Therapeutics SLXN Slips 3 as Shares Test Key Support at 040 Pacific Northwest City Leads Home Price Declines as Housing Weakness Broadens ARMK Q1 2026 Earnings Earnings Slightly Miss Estimates Amid Operational Improvements Atkore Inc ATKR Surges 1125 Electrical Infrastructure Demand Fuels Rally Theriva Biologics TOVX Q1 2026 Earnings Narrowed Loss Beats Expectations as Stock Rises CLDX Q1 2026 Earnings Slight EPS Miss as DevelopmentStage Biotech Continues NoRevenue Phase ZION Q1 2026 Earnings EPS Surprise Beats Estimates Amid Cautious Banking Environment C4 Therapeutics Q1 2026 Earnings Strong EPS Beat Highlights Cost Discipline Amid PreRevenue Stage CALX Q1 2026 Earnings EPS Matches Estimates Stock Rises 211 THM Q1 2026 Earnings Minimal EPS Reported No Revenue as Development Continues ColgatePalmolive Q1 2026 Earnings Slight EPS Miss Amid Positive Stock Movement